Modulation of the malignant phenotype with the urokinase-type plasminogen activator and the type I plasminogen activator inhibitor

This publication has 10 references indexed in Scilit:

• Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells.
  Proceedings of the National Academy of Sciences, 1990
• Metastatic Inefficiency
  Advances in Cancer Research, 1990
• Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion.
  The Journal of cell biology, 1989
• Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells.
  Molecular and Cellular Biology, 1989
• Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
  The Journal of cell biology, 1989
• In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase.
  The Journal of cell biology, 1988
• Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells
  The Journal of cell biology, 1987
• Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines
  International Journal of Cancer, 1986
• Plasminogen Activators, Tissue Degradation, and Cancer
  Published by Elsevier ,1985
• Antibodies to plasminogen activator inhibit human tumor metastasis
  Cell, 1983